(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SCINOMED BLOOD PROCESSING SOLUTIONS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SCINOMED BLOOD PROCESSING SOLUTIONS

ST13

US500000079210239

Class

44

Filing

79210239

Registration

5893585

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

53

Latest update

06/09/2026

Trademark type

Combined

Nice classes

44

Filing date

03/27/2017

Registration date

10/29/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/15/2026

Last transaction

06/09/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

98

Owner location

GB

Examiner

GAGLIARDI, JEANINE

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "SCINOMED" in black font above the wording "BLOOD PROCESSING SOLUTIONS" in red font, all below a design of three red blood cells in red. The color white represents background and is not part of the mark.

Holders and representatives

Holders

Scinomed Ltd

Representatives

JAMES L SCOTT WARNER NORCROSS & JUDD LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical services; medical advisory services; medical advisory services in relation to medical apparatus and instruments; consultancy services for the medical industryconsultancy services in the field of medical care; consultancy services in relation to the collection and processing of blood for medical purposes; information services in relation to all of the aforesaid

Publications

History of USPTO decisions and trademark events.

53 publications found

C71T

CANCELLED SECTION 71

05/15/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/21/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/29/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/08/2024

FINP

FINAL DECISION TRANSACTION PROCESSED BY IB

03/13/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/27/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/06/2020

FIMP

FINAL DISPOSITION PROCESSED

03/06/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/29/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

10/29/2019

GPNX

NOTIFICATION PROCESSED BY IB

08/23/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/13/2019

PUBO

PUBLISHED FOR OPPOSITION

08/13/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/24/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/24/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/24/2019

ALIE

ASSIGNED TO LIE

07/08/2019

EXPT

EXPARTE APPEAL TERMINATED

06/27/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/26/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/05/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/04/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/04/2019

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

12/15/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/06/2018

GNRT

NON-FINAL ACTION E-MAILED

12/06/2018

CNRT

NON-FINAL ACTION WRITTEN

12/06/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/28/2018

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

11/28/2018

DPCC

DIVISIONAL PROCESSING COMPLETE

11/21/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/16/2018

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

10/06/2018

DOCK

ASSIGNED TO EXAMINER

10/05/2018

DRRR

DIVISIONAL REQUEST RECEIVED

10/03/2018

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/03/2018

EXPI

EX PARTE APPEAL-INSTITUTED

10/03/2018

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

10/03/2018

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

10/03/2018

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

10/03/2018

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/03/2018

GNFR

FINAL REFUSAL E-MAILED

04/03/2018

CNFR

FINAL REFUSAL WRITTEN

04/03/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/05/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/05/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/05/2018

RFNT

REFUSAL PROCESSED BY IB

07/28/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/08/2017

RFRR

REFUSAL PROCESSED BY MPU

07/08/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/29/2017

CNRT

NON-FINAL ACTION WRITTEN

06/28/2017

MAFR

APPLICATION FILING RECEIPT MAILED

06/27/2017

DOCK

ASSIGNED TO EXAMINER

06/23/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/23/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/22/2017

Continuous trademark protection

Get notified about every new filing that threatens SCINOMED BLOOD PROCESSING SOLUTIONS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.